You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 3, March 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuropathy Following Exposure to a Dimethylamine Salt of 2, 4-D

MARY C. BERKLEY, M.D.; KENNETH R. MAGEE, M.D.

Arch Intern Med. 1963;111(3):351-352.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A case of peripheral neuritis followed exposure to the dimethylamine salt of 2,4-dichlorophenoxyacetic acid. 2,4-D is widely used as a weed killer. In minute doses, plant growth is stimulated; but in concentrations employed in ordinary commercial herbicides, this chemical causes excessive stimulation resulting in death to the plant.

Although 2,4-D is usually nontoxic, in 1959, Goldstein, Jones, and Brown reported 3 cases of peripheral neuropathy following exposure to an ester of 2,4-D.1 The neuropathy began shortly after the exposure to the skin; therefore, absorption seemed to be percutaneous. Disability was prolonged, and recovery was incomplete. Prior to this report there had been no evidence of serious toxic effect in humans. However, various toxic reactions had been reported in animals, including renal edema with tubular changes, liver damage, myotonia, stiffness of the extremities, ataxia, lethargy, paralysis, and coma.

Goldstein, Jones, and Brown did not describe details of manufacture or purity . . . [Full Text PDF of this Article]


Author Affiliations

ANN ARBOR, MICH.

From the Department of Neurology, University of Michigan Medical Center.


Footnotes

Received for publication Oct. 9, 1962; accepted Nov. 12.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.